HEADER TRANSFERASE INHIBITOR 01-MAY-08 3D0E TITLE CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-BETA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: RAC-PK-BETA, PROTEIN KINASE AKT-2, PROTEIN KINASE B, BETA, COMPND 6 PKB BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: AKT2; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HUMAN, AKT2, INHIBITOR, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, KEYWDS 3 TRANSFERASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR N.O.CONCHA,A.SMALLWOOD REVDAT 6 25-OCT-17 3D0E 1 REMARK REVDAT 5 28-DEC-16 3D0E 1 HETSYN REVDAT 4 13-JUL-11 3D0E 1 VERSN REVDAT 3 20-APR-11 3D0E 1 HET REVDAT 2 24-FEB-09 3D0E 1 VERSN REVDAT 1 21-OCT-08 3D0E 0 JRNL AUTH D.A.HEERDING,N.RHODES,J.D.LEBER,T.J.CLARK,R.M.KEENAN, JRNL AUTH 2 L.V.LAFRANCE,M.LI,I.G.SAFONOV,D.T.TAKATA,J.W.VENSLAVSKY, JRNL AUTH 3 D.S.YAMASHITA,A.E.CHOUDHRY,R.A.COPELAND,Z.LAI,M.D.SCHABER, JRNL AUTH 4 P.J.TUMMINO,S.L.STRUM,E.R.WOOD,D.R.DUCKETT,D.EBERWEIN, JRNL AUTH 5 V.B.KNICK,T.J.LANSING,R.T.MCCONNELL,S.ZHANG,E.A.MINTHORN, JRNL AUTH 6 N.O.CONCHA,G.L.WARREN,R.KUMAR JRNL TITL IDENTIFICATION OF JRNL TITL 2 4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-{[(3S) JRNL TITL 3 -3-PIPERIDINYLMETHYL]OXY}-1H-IMIDAZO[4,5-C]PYRIDIN-4-YL) JRNL TITL 4 -2-METHYL-3-BUTYN-2-OL (GSK690693), A NOVEL INHIBITOR OF AKT JRNL TITL 5 KINASE. JRNL REF J.MED.CHEM. V. 51 5663 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18800763 JRNL DOI 10.1021/JM8004527 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 46277 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2346 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3331 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE SET COUNT : 173 REMARK 3 BIN FREE R VALUE : 0.3620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5314 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 450 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.46000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : -0.69000 REMARK 3 B12 (A**2) : 0.23000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.223 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.182 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.744 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5506 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3848 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7440 ; 1.269 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9300 ; 0.811 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 644 ; 5.566 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 268 ;35.161 ;23.209 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 968 ;11.922 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;16.983 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 790 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6016 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1186 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1126 ; 0.181 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4009 ; 0.179 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2625 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2745 ; 0.079 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 389 ; 0.139 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 26 ; 0.148 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 114 ; 0.267 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 36 ; 0.125 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4223 ; 0.569 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1306 ; 0.066 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5216 ; 0.609 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2732 ; 0.850 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2224 ; 1.228 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 146 A 480 5 REMARK 3 1 B 146 B 480 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1909 ; 0.040 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 2655 ; 0.270 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1909 ; 0.120 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2655 ; 0.250 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 146 A 480 REMARK 3 ORIGIN FOR THE GROUP (A): 15.6613 -18.6016 3.7316 REMARK 3 T TENSOR REMARK 3 T11: -0.0276 T22: -0.0745 REMARK 3 T33: -0.0504 T12: -0.0187 REMARK 3 T13: 0.0079 T23: 0.0053 REMARK 3 L TENSOR REMARK 3 L11: 0.9658 L22: 0.7675 REMARK 3 L33: 0.9798 L12: 0.5551 REMARK 3 L13: -0.0687 L23: -0.2619 REMARK 3 S TENSOR REMARK 3 S11: 0.0748 S12: -0.0053 S13: -0.0027 REMARK 3 S21: 0.0319 S22: -0.0732 S23: -0.0636 REMARK 3 S31: -0.1121 S32: 0.0339 S33: -0.0016 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 146 B 480 REMARK 3 ORIGIN FOR THE GROUP (A): 23.9523 -63.0005 -3.7824 REMARK 3 T TENSOR REMARK 3 T11: -0.0511 T22: -0.0550 REMARK 3 T33: -0.0548 T12: 0.0312 REMARK 3 T13: 0.0011 T23: 0.0100 REMARK 3 L TENSOR REMARK 3 L11: 0.3183 L22: 1.5257 REMARK 3 L33: 0.9553 L12: -0.2033 REMARK 3 L13: 0.1979 L23: -0.2658 REMARK 3 S TENSOR REMARK 3 S11: -0.0389 S12: 0.0366 S13: 0.0429 REMARK 3 S21: 0.0746 S22: 0.0372 S23: -0.0337 REMARK 3 S31: -0.0746 S32: -0.0725 S33: 0.0017 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3D0E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047433. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46301 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 35.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.61500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 4K, 10% ISOPROPANOL, PH 8.0, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.07933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 15.03967 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 455 REMARK 465 TYR A 456 REMARK 465 ASP A 457 REMARK 465 SER A 458 REMARK 465 LEU A 459 REMARK 465 GLY A 460 REMARK 465 LEU A 461 REMARK 465 LEU A 462 REMARK 465 GLU A 463 REMARK 465 LEU A 464 REMARK 465 ASP A 465 REMARK 465 ARG B 455 REMARK 465 TYR B 456 REMARK 465 ASP B 457 REMARK 465 SER B 458 REMARK 465 LEU B 459 REMARK 465 GLY B 460 REMARK 465 LEU B 461 REMARK 465 LEU B 462 REMARK 465 GLU B 463 REMARK 465 LEU B 464 REMARK 465 ASP B 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 245 -42.14 77.26 REMARK 500 ARG A 274 -5.28 68.95 REMARK 500 ASP A 293 84.21 61.89 REMARK 500 ASN A 325 -149.31 77.07 REMARK 500 ASP A 399 -117.33 55.14 REMARK 500 GLN A 429 39.17 -90.23 REMARK 500 ASP A 474 37.41 -141.15 REMARK 500 ARG B 245 -42.30 75.29 REMARK 500 ARG B 274 -0.10 69.10 REMARK 500 ASP B 293 83.67 62.61 REMARK 500 ASN B 325 -148.72 70.95 REMARK 500 ASP B 399 -118.63 54.46 REMARK 500 GLN B 429 43.88 -90.44 REMARK 500 PHE B 473 61.27 -118.98 REMARK 500 ASP B 474 43.06 -153.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G93 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G93 B 2 DBREF 3D0E A 146 480 UNP P31751 AKT2_HUMAN 146 480 DBREF 3D0E B 146 480 UNP P31751 AKT2_HUMAN 146 480 SEQADV 3D0E ASP A 474 UNP P31751 SER 474 VARIANT SEQADV 3D0E ASP B 474 UNP P31751 SER 474 VARIANT SEQRES 1 A 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 A 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 A 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 A 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 A 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 A 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 A 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 A 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 A 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 A 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 A 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 A 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 A 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 A 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 A 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 A 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 A 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 A 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 A 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 A 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 A 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 A 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 A 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 A 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 A 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 A 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG SEQRES 1 B 335 LYS VAL THR MET ASN ASP PHE ASP TYR LEU LYS LEU LEU SEQRES 2 B 335 GLY LYS GLY THR PHE GLY LYS VAL ILE LEU VAL ARG GLU SEQRES 3 B 335 LYS ALA THR GLY ARG TYR TYR ALA MET LYS ILE LEU ARG SEQRES 4 B 335 LYS GLU VAL ILE ILE ALA LYS ASP GLU VAL ALA HIS THR SEQRES 5 B 335 VAL THR GLU SER ARG VAL LEU GLN ASN THR ARG HIS PRO SEQRES 6 B 335 PHE LEU THR ALA LEU LYS TYR ALA PHE GLN THR HIS ASP SEQRES 7 B 335 ARG LEU CYS PHE VAL MET GLU TYR ALA ASN GLY GLY GLU SEQRES 8 B 335 LEU PHE PHE HIS LEU SER ARG GLU ARG VAL PHE THR GLU SEQRES 9 B 335 GLU ARG ALA ARG PHE TYR GLY ALA GLU ILE VAL SER ALA SEQRES 10 B 335 LEU GLU TYR LEU HIS SER ARG ASP VAL VAL TYR ARG ASP SEQRES 11 B 335 ILE LYS LEU GLU ASN LEU MET LEU ASP LYS ASP GLY HIS SEQRES 12 B 335 ILE LYS ILE THR ASP PHE GLY LEU CYS LYS GLU GLY ILE SEQRES 13 B 335 SER ASP GLY ALA THR MET LYS TPO PHE CYS GLY THR PRO SEQRES 14 B 335 GLU TYR LEU ALA PRO GLU VAL LEU GLU ASP ASN ASP TYR SEQRES 15 B 335 GLY ARG ALA VAL ASP TRP TRP GLY LEU GLY VAL VAL MET SEQRES 16 B 335 TYR GLU MET MET CYS GLY ARG LEU PRO PHE TYR ASN GLN SEQRES 17 B 335 ASP HIS GLU ARG LEU PHE GLU LEU ILE LEU MET GLU GLU SEQRES 18 B 335 ILE ARG PHE PRO ARG THR LEU SER PRO GLU ALA LYS SER SEQRES 19 B 335 LEU LEU ALA GLY LEU LEU LYS LYS ASP PRO LYS GLN ARG SEQRES 20 B 335 LEU GLY GLY GLY PRO SER ASP ALA LYS GLU VAL MET GLU SEQRES 21 B 335 HIS ARG PHE PHE LEU SER ILE ASN TRP GLN ASP VAL VAL SEQRES 22 B 335 GLN LYS LYS LEU LEU PRO PRO PHE LYS PRO GLN VAL THR SEQRES 23 B 335 SER GLU VAL ASP THR ARG TYR PHE ASP ASP GLU PHE THR SEQRES 24 B 335 ALA GLN SER ILE THR ILE TPO PRO PRO ASP ARG TYR ASP SEQRES 25 B 335 SER LEU GLY LEU LEU GLU LEU ASP GLN ARG THR HIS PHE SEQRES 26 B 335 PRO GLN PHE ASP TYR SER ALA SER ILE ARG MODRES 3D0E TPO A 309 THR PHOSPHOTHREONINE MODRES 3D0E TPO A 451 THR PHOSPHOTHREONINE MODRES 3D0E TPO B 309 THR PHOSPHOTHREONINE MODRES 3D0E TPO B 451 THR PHOSPHOTHREONINE HET TPO A 309 11 HET TPO A 451 11 HET TPO B 309 11 HET TPO B 451 11 HET G93 A 1 31 HET G93 B 2 31 HETNAM TPO PHOSPHOTHREONINE HETNAM G93 4-{2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-[(3S)- HETNAM 2 G93 PIPERIDIN-3-YLMETHOXY]-1H-IMIDAZO[4,5-C]PYRIDIN-4-YL}- HETNAM 3 G93 2-METHYLBUT-3-YN-2-OL HETSYN TPO PHOSPHONOTHREONINE HETSYN G93 GSK690693 FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 3 G93 2(C21 H27 N7 O3) FORMUL 5 HOH *450(H2 O) HELIX 1 1 THR A 148 ASN A 150 5 3 HELIX 2 2 LYS A 185 LYS A 191 1 7 HELIX 3 3 GLU A 193 THR A 207 1 15 HELIX 4 4 GLU A 236 ARG A 245 1 10 HELIX 5 5 THR A 248 ARG A 269 1 22 HELIX 6 6 LYS A 277 GLU A 279 5 3 HELIX 7 7 THR A 313 LEU A 317 5 5 HELIX 8 8 ALA A 318 GLU A 323 5 6 HELIX 9 9 ALA A 330 GLY A 346 1 17 HELIX 10 10 ASP A 354 GLU A 365 1 12 HELIX 11 11 SER A 374 LEU A 385 1 12 HELIX 12 12 ASP A 399 GLU A 405 1 7 HELIX 13 13 HIS A 406 LEU A 410 5 5 HELIX 14 14 ASN A 413 GLN A 419 1 7 HELIX 15 15 ASP A 440 ALA A 445 1 6 HELIX 16 16 THR B 148 ASN B 150 5 3 HELIX 17 17 LYS B 185 LYS B 191 1 7 HELIX 18 18 GLU B 193 THR B 207 1 15 HELIX 19 19 GLU B 236 ARG B 245 1 10 HELIX 20 20 THR B 248 ARG B 269 1 22 HELIX 21 21 LYS B 277 GLU B 279 5 3 HELIX 22 22 THR B 313 LEU B 317 5 5 HELIX 23 23 ALA B 318 GLU B 323 5 6 HELIX 24 24 ALA B 330 GLY B 346 1 17 HELIX 25 25 ASP B 354 GLU B 365 1 12 HELIX 26 26 SER B 374 LEU B 385 1 12 HELIX 27 27 ASP B 399 GLU B 405 1 7 HELIX 28 28 HIS B 406 LEU B 410 5 5 HELIX 29 29 ASN B 413 GLN B 419 1 7 HELIX 30 30 ASP B 440 ALA B 445 1 6 SHEET 1 A 6 PHE A 152 LYS A 160 0 SHEET 2 A 6 LYS A 165 GLU A 171 -1 O LEU A 168 N LYS A 156 SHEET 3 A 6 TYR A 177 ARG A 184 -1 O ILE A 182 N LYS A 165 SHEET 4 A 6 ARG A 224 MET A 229 -1 O MET A 229 N ALA A 179 SHEET 5 A 6 LEU A 215 GLN A 220 -1 N PHE A 219 O CYS A 226 SHEET 6 A 6 TYR A 475 SER A 476 -1 O TYR A 475 N ALA A 218 SHEET 1 B 2 LEU A 281 LEU A 283 0 SHEET 2 B 2 ILE A 289 ILE A 291 -1 O LYS A 290 N MET A 282 SHEET 1 C 6 PHE B 152 LYS B 160 0 SHEET 2 C 6 LYS B 165 GLU B 171 -1 O LEU B 168 N LYS B 156 SHEET 3 C 6 TYR B 177 ARG B 184 -1 O ILE B 182 N LYS B 165 SHEET 4 C 6 ARG B 224 MET B 229 -1 O MET B 229 N ALA B 179 SHEET 5 C 6 LEU B 215 GLN B 220 -1 N PHE B 219 O CYS B 226 SHEET 6 C 6 TYR B 475 SER B 476 -1 O TYR B 475 N ALA B 218 SHEET 1 D 2 LEU B 281 LEU B 283 0 SHEET 2 D 2 ILE B 289 ILE B 291 -1 O LYS B 290 N MET B 282 LINK C LYS A 308 N TPO A 309 1555 1555 1.33 LINK C TPO A 309 N PHE A 310 1555 1555 1.33 LINK C ILE A 450 N TPO A 451 1555 1555 1.33 LINK C TPO A 451 N PRO A 452 1555 1555 1.35 LINK C LYS B 308 N TPO B 309 1555 1555 1.33 LINK C TPO B 309 N PHE B 310 1555 1555 1.33 LINK C ILE B 450 N TPO B 451 1555 1555 1.33 LINK C TPO B 451 N PRO B 452 1555 1555 1.35 SITE 1 AC1 15 ALA A 179 LYS A 181 GLU A 200 LEU A 204 SITE 2 AC1 15 PHE A 227 MET A 229 GLU A 230 TYR A 231 SITE 3 AC1 15 ALA A 232 GLU A 236 GLU A 279 MET A 282 SITE 4 AC1 15 ASP A 293 PHE A 294 PHE A 439 SITE 1 AC2 15 ALA B 179 LYS B 181 GLU B 200 LEU B 204 SITE 2 AC2 15 PHE B 227 MET B 229 GLU B 230 TYR B 231 SITE 3 AC2 15 ALA B 232 GLU B 236 GLU B 279 MET B 282 SITE 4 AC2 15 ASP B 293 PHE B 294 PHE B 439 CRYST1 116.489 116.489 45.119 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008585 0.004956 0.000000 0.00000 SCALE2 0.000000 0.009913 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022164 0.00000